[HTML][HTML] Tiotropium/olodaterol delays clinically important deterioration compared with tiotropium monotherapy in patients with early COPD: a post hoc analysis of the …
Introduction Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KF Rabe, JD Chalmers, M Miravitlles… - Advances in …, 2020 - europepmc.org
Methods Data were analysed from 2055 patients treated with either tiotropium/olodaterol 5/5
μg or tiotropium 5 μg (delivered via Respimat®) in two replicate, 52-week, parallel-group …
μg or tiotropium 5 μg (delivered via Respimat®) in two replicate, 52-week, parallel-group …
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KF Rabe, JD Chalmers, M Miravitlles… - Advances in …, 2021 - discovery.dundee.ac.uk
Introduction: Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
[HTML][HTML] Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of …
KF Rabe, JD Chalmers, M Miravitlles… - Advances in …, 2021 - ncbi.nlm.nih.gov
Methods Data were analysed from 2055 patients treated with either tiotropium/olodaterol 5/5
μg or tiotropium 5 μg (delivered via Respimat®) in two replicate, 52-week, parallel-group …
μg or tiotropium 5 μg (delivered via Respimat®) in two replicate, 52-week, parallel-group …
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KF Rabe, JD Chalmers, M Miravitlles… - Advances in …, 2021 - research.rug.nl
Introduction Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
[PDF][PDF] Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KFRJD Chalmers, M Miravitlles - Adv Ther, 2021 - scholar.archive.org
Introduction: Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
[PDF][PDF] Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KFRJD Chalmers, M Miravitlles - Adv Ther, 2021 - core.ac.uk
Introduction: Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KF Rabe, JD Chalmers, M Miravitlles, JWH Kocks… - 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
[PDF][PDF] Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KFRJD Chalmers, M Miravitlles - Adv Ther, 2021 - core.ac.uk
Introduction: Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
[PDF][PDF] Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the …
KFRJD Chalmers, M Miravitlles - 2020 - discovery.dundee.ac.uk
Introduction: Since chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, a composite endpoint of clinically important deterioration (CID) may provide a …
condition, a composite endpoint of clinically important deterioration (CID) may provide a …